Cargando…

Prescription opioids and economic hardship in France

This paper studies how opioid analgesic sales are empirically related to socioeconomic disparities in France, with a focus on poverty. This analysis is made possible using the OpenHealth database, which provides retail sales data for opioid analgesics available on the French market. We exploit firm-...

Descripción completa

Detalles Bibliográficos
Autores principales: Natali, Ilaria, Dewatripont, Mathias, Ginsburgh, Victor, Goldman, Michel, Legros, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884604/
https://www.ncbi.nlm.nih.gov/pubmed/36710287
http://dx.doi.org/10.1007/s10198-022-01557-4
_version_ 1784879752412135424
author Natali, Ilaria
Dewatripont, Mathias
Ginsburgh, Victor
Goldman, Michel
Legros, Patrick
author_facet Natali, Ilaria
Dewatripont, Mathias
Ginsburgh, Victor
Goldman, Michel
Legros, Patrick
author_sort Natali, Ilaria
collection PubMed
description This paper studies how opioid analgesic sales are empirically related to socioeconomic disparities in France, with a focus on poverty. This analysis is made possible using the OpenHealth database, which provides retail sales data for opioid analgesics available on the French market. We exploit firm-level data for each of the 94 departments in Metropolitan France between 2008 and 2017. We show that increases in the poverty rate are associated with increases in sales: a one percentage point increase in poverty is associated with approximately a 5% increase in mild opioid sales. Our analysis further shows that opioid sales are positively related to the share of middle-aged people and individuals with basic education only, while they are negatively related to population density. The granularity and longitudinal nature of these data allow us to control for a large pool of potential confounding factors. Our results suggest that additional interventions should be more intensively addressed toward the most deprived areas. We conclude that a combination of policies aimed at improving economic prospects and strictly monitoring access to opioid medications would be beneficial for reducing opioid-related harm.
format Online
Article
Text
id pubmed-9884604
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-98846042023-01-30 Prescription opioids and economic hardship in France Natali, Ilaria Dewatripont, Mathias Ginsburgh, Victor Goldman, Michel Legros, Patrick Eur J Health Econ Original Paper This paper studies how opioid analgesic sales are empirically related to socioeconomic disparities in France, with a focus on poverty. This analysis is made possible using the OpenHealth database, which provides retail sales data for opioid analgesics available on the French market. We exploit firm-level data for each of the 94 departments in Metropolitan France between 2008 and 2017. We show that increases in the poverty rate are associated with increases in sales: a one percentage point increase in poverty is associated with approximately a 5% increase in mild opioid sales. Our analysis further shows that opioid sales are positively related to the share of middle-aged people and individuals with basic education only, while they are negatively related to population density. The granularity and longitudinal nature of these data allow us to control for a large pool of potential confounding factors. Our results suggest that additional interventions should be more intensively addressed toward the most deprived areas. We conclude that a combination of policies aimed at improving economic prospects and strictly monitoring access to opioid medications would be beneficial for reducing opioid-related harm. Springer Berlin Heidelberg 2023-01-30 2023 /pmc/articles/PMC9884604/ /pubmed/36710287 http://dx.doi.org/10.1007/s10198-022-01557-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Paper
Natali, Ilaria
Dewatripont, Mathias
Ginsburgh, Victor
Goldman, Michel
Legros, Patrick
Prescription opioids and economic hardship in France
title Prescription opioids and economic hardship in France
title_full Prescription opioids and economic hardship in France
title_fullStr Prescription opioids and economic hardship in France
title_full_unstemmed Prescription opioids and economic hardship in France
title_short Prescription opioids and economic hardship in France
title_sort prescription opioids and economic hardship in france
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884604/
https://www.ncbi.nlm.nih.gov/pubmed/36710287
http://dx.doi.org/10.1007/s10198-022-01557-4
work_keys_str_mv AT nataliilaria prescriptionopioidsandeconomichardshipinfrance
AT dewatripontmathias prescriptionopioidsandeconomichardshipinfrance
AT ginsburghvictor prescriptionopioidsandeconomichardshipinfrance
AT goldmanmichel prescriptionopioidsandeconomichardshipinfrance
AT legrospatrick prescriptionopioidsandeconomichardshipinfrance